Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of cellular and molecular medicine"
DOI: 10.1111/jcmm.16999
Abstract: Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) is considered to be… read more here.
Keywords: triple hit; dose rituximab; high dose; hit lymphoma ... See more keywords